Description:FIELD OF THE INVENTION
The field of the present invention pertains to the domain of computational fluid dynamics (CFD), biomedical engineering, and mathematical modeling, specifically focusing on the simulation and analysis of peristaltic transport of non-Newtonian fluids within biological conduits. This invention addresses the critical need to understand and predict the complex transport mechanisms involved in various physiological systems, such as the gastrointestinal tract, urinary pathways, reproductive tracts, and microcirculatory blood flow, where the movement of fluids is governed by peristaltic waves along flexible, elastic conduits. The invention is designed to simulate non-Newtonian fluid behavior, characterized by variable viscosity and nonlinear flow properties, which are common in biological fluids like blood, mucus, chyme, and synovial fluid. By utilizing advanced computational algorithms, numerical solvers, and rheological models, the system can accurately replicate shear-thinning, shear-thickening, and viscoplastic behaviors under peristaltic motion. This field of invention also integrates physiological parameters such as conduit elasticity, wave amplitude, frequency, and wavelength to emulate realistic biological conditions. The computational framework serves not only as a predictive and diagnostic tool for medical research but also aids in the design and optimization of biomedical devices, such as peristaltic pumps and targeted drug delivery systems. Furthermore, it facilitates educational and research endeavors by providing a platform for visualizing and analyzing the interactions between non-Newtonian fluids and deformable biological structures. Overall, this invention bridges the gap between theoretical modeling and practical biomedical applications, contributing to advancements in personalized medicine, biomedical device engineering, and physiological research.

Background of the proposed invention:

The peristaltic transport of fluids through biological conduits is a fundamental physiological process crucial to the functioning of various systems within the human body, including the gastrointestinal tract, urinary system, reproductive organs, and vascular networks. This mechanism involves the rhythmic contraction and relaxation of muscles in the walls of biological conduits, generating a wave-like motion that propels fluids forward. Understanding this process is essential not only for physiological comprehension but also for diagnosing and treating a range of disorders associated with impaired or abnormal peristaltic motion, such as gastroesophageal reflux disease, achalasia, intestinal obstructions, urinary reflux, and vascular pathologies. Traditionally, the analysis of peristaltic transport has been approached through experimental studies and simplified theoretical models based on Newtonian fluid dynamics. However, biological fluids typically exhibit non-Newtonian characteristics, displaying complex rheological behaviors such as shear-thinning, shear-thickening, viscoplasticity, and yield stress phenomena, which cannot be accurately captured by conventional Newtonian models. For instance, blood exhibits shear-thinning behavior due to the presence of red blood cells, while mucus and synovial fluid demonstrate viscoelastic properties that significantly influence flow dynamics under peristaltic motion. Additionally, the conduits themselves, such as intestines, ureters, and blood vessels, are not rigid but elastic and deformable, further complicating the flow behavior. The interplay between non-Newtonian fluid properties and the flexible walls of biological conduits under peristaltic waves presents a highly nonlinear and coupled problem that demands sophisticated modeling and simulation techniques. Existing computational approaches have been limited in scope, often constrained to simplified geometries, steady flow assumptions, or specific rheological models, which do not adequately reflect the physiological realities. Moreover, many studies neglect the impact of conduit elasticity, wave propagation characteristics, and the interaction between fluid and wall dynamics, leading to incomplete or inaccurate predictions of flow behavior, pressure distribution, wall shear stress, and potential sites of flow obstruction or stasis. The need for a comprehensive computational system that can model these complexities has become increasingly critical, particularly with the growing emphasis on personalized medicine, where simulations tailored to individual patient anatomy and physiology can guide clinical decision-making and therapeutic interventions. Advances in computational fluid dynamics, numerical methods, and high-performance computing have made it feasible to develop such a system, capable of handling the intricate details of peristaltic transport in non-Newtonian fluids within elastic biological conduits. By integrating robust rheological models like Power-law, Bingham plastic, and Herschel-Bulkley formulations, along with sophisticated numerical solvers for partial differential equations governing fluid flow and wall deformation, the proposed system can provide accurate and detailed simulations of peristaltic transport under varying physiological and pathological conditions. This capability is particularly valuable in the design and optimization of biomedical devices such as peristaltic pumps, artificial conduits, and targeted drug delivery systems that rely on controlled fluid transport. It also holds potential for enhancing diagnostic tools by identifying abnormal flow patterns or mechanical stresses that may contribute to disease progression. Furthermore, the educational and research implications are significant, as the system offers a platform for visualizing complex flow phenomena, testing hypotheses about fluid-structure interactions, and training students and researchers in the interdisciplinary fields of biomechanics, fluid dynamics, and computational modeling. The background of this invention is rooted in the convergence of biomedical engineering, applied mathematics, and computational sciences, addressing a longstanding gap in the simulation and analysis of biological transport mechanisms. As healthcare increasingly moves towards precision and personalized solutions, the ability to simulate individual-specific conditions, predict outcomes, and optimize interventions through computational models becomes indispensable. Therefore, the development of a comprehensive computational system for simulating peristaltic transport of non-Newtonian fluids in biological conduits represents a significant advancement, enabling more accurate modeling of physiological processes, better-informed medical interventions, and innovative device engineering that collectively contribute to improved healthcare outcomes and scientific understanding.

Summary of the proposed invention:

The proposed invention, titled "Computational System for Simulating Peristaltic Transport of Non-Newtonian Fluids in Biological Conduits," represents a novel and advanced computational framework designed to model, simulate, and analyze the complex dynamics of non-Newtonian fluid flow driven by peristaltic motion within flexible and elastic biological conduits. Peristaltic transport is a critical physiological mechanism responsible for the movement of various biological fluids such as blood, mucus, chyme, and urine through conduits like the gastrointestinal tract, urinary system, reproductive organs, and vascular pathways. This transport process is characterized by the generation of rhythmic, wave-like contractions along the walls of the conduits, which interact intricately with the fluid’s rheological properties and the elasticity of the surrounding tissues. The proposed invention addresses the significant challenges associated with simulating these phenomena by incorporating advanced numerical methods capable of solving complex, coupled partial differential equations that govern fluid dynamics, wall motion, and fluid-structure interactions under peristaltic conditions. Unlike existing models that often simplify assumptions by treating fluids as Newtonian and conduits as rigid or quasi-rigid, this system comprehensively integrates various non-Newtonian fluid models such as Power-law, Bingham plastic, Casson, and Herschel-Bulkley models to capture shear-thinning, shear-thickening, viscoelasticity, and yield stress behaviors observed in real biological fluids. Furthermore, the elasticity, compliance, and dynamic deformation of biological conduits are explicitly modeled using biomechanical principles, ensuring a realistic representation of the physiological environment. The system leverages finite element methods (FEM), finite difference methods (FDM), and computational fluid dynamics (CFD) algorithms to resolve the nonlinearities inherent in the fluid and wall interactions, enabling accurate predictions of flow parameters such as velocity profiles, pressure gradients, wall shear stress, particle trajectories, and potential sites of flow stagnation or turbulence. A key feature of this invention is its adaptability and customization capability, wherein anatomical and physiological parameters such as conduit diameter, wall thickness, wave amplitude, wavelength, frequency, fluid consistency, and density can be adjusted to simulate specific organs, patient conditions, or disease states. This adaptability enables clinicians and researchers to create patient-specific models that can predict how peristaltic transport is altered in pathological conditions like diabetes-induced gastroparesis, ureteral obstructions, or cardiovascular anomalies involving microcirculatory dysfunction. The system is equipped with a user-friendly graphical user interface (GUI) that allows for easy input of parameters, visualization of real-time simulations, and comprehensive data analytics tools for interpreting results. This interactive interface facilitates use by biomedical engineers, researchers, healthcare professionals, and educators who may not have extensive computational expertise but require precise simulation capabilities for their work. Additionally, the system incorporates machine learning algorithms that can learn from simulation outcomes to optimize input parameters for desired flow characteristics or therapeutic objectives, thereby enhancing predictive accuracy and personalization. The invention supports applications in the design and optimization of biomedical devices such as peristaltic pumps, stents, drug delivery mechanisms, and artificial organs, where controlled transport of complex fluids is critical. It provides a robust platform for virtual prototyping, reducing the reliance on expensive and time-consuming physical trials. In medical diagnostics and therapeutics, the system can help in identifying abnormal flow patterns, regions of excessive mechanical stress on tissues, and the risk of flow-induced complications, thereby aiding in the planning of surgical interventions or targeted therapies. From a research perspective, the invention enables the exploration of fundamental questions related to biomechanics, rheology, and fluid-structure interactions in biological systems, promoting interdisciplinary studies that bridge physiology, engineering, and computational sciences. It also serves as an educational tool for training students in medical, engineering, and scientific disciplines by providing visual and quantitative insights into the complexities of biological fluid transport. The computational framework is designed to be scalable and compatible with high-performance computing environments, ensuring that large-scale, high-resolution simulations can be conducted efficiently for both academic and industrial applications. The invention also includes capabilities for multi-scale modeling, linking microscale phenomena such as cellular interactions and particle dynamics with macroscale flow behavior to provide a holistic understanding of transport mechanisms. Additionally, the system is built with modularity in mind, allowing for the integration of emerging rheological models, biomechanical data, and clinical imaging inputs such as MRI or CT scans to enhance model accuracy and relevance. This modular approach ensures that the system remains adaptable to new scientific findings and technological advancements. In summary, the proposed computational system represents a significant leap forward in simulating and understanding peristaltic transport of non-Newtonian fluids within biological conduits, offering comprehensive, accurate, and customizable modeling capabilities that have broad applications in biomedical engineering, clinical research, device design, diagnostics, and education. By bridging theoretical modeling with practical applications, this invention paves the way for more precise and effective healthcare solutions, contributing to the advancement of personalized medicine, improved biomedical devices, and a deeper scientific understanding of the fluid dynamics underlying human physiology.

Brief description of the proposed invention:

The proposed invention titled "Computational System for Simulating Peristaltic Transport of Non-Newtonian Fluids in Biological Conduits" presents an innovative and comprehensive computational framework that is meticulously designed to model, simulate, and analyze the intricate process of peristaltic transport of non-Newtonian fluids through elastic, flexible biological conduits under various physiological and pathological conditions. Peristaltic transport, an essential biological mechanism, involves the progressive wave-like contractions along the walls of conduits such as the gastrointestinal tract, ureters, vas deferens, fallopian tubes, and microcirculatory blood vessels, facilitating the movement of complex fluids like chyme, mucus, urine, and blood that inherently exhibit non-Newtonian properties such as shear-thinning, shear-thickening, viscoelasticity, and yield stress behaviors. Recognizing the limitations of conventional Newtonian-based models and rigid wall assumptions in capturing the true dynamics of such physiological processes, the invention leverages advanced computational fluid dynamics (CFD), finite element methods (FEM), and finite difference methods (FDM) to solve the highly nonlinear and coupled partial differential equations that govern the interactions between the non-Newtonian fluid and the compliant, deformable walls of the conduits. This system is capable of simulating a wide range of rheological behaviors through the integration of sophisticated fluid models including Power-law, Bingham plastic, Casson, and Herschel-Bulkley models, enabling the accurate depiction of diverse biological fluids under various flow regimes and mechanical stimuli. The computational engine is further enhanced with fluid-structure interaction (FSI) capabilities, ensuring that the dynamic response of the conduit walls to peristaltic waves and the consequent impact on fluid transport are accurately captured. The system allows customization of key physiological parameters such as conduit diameter, wall elasticity, amplitude, wavelength, frequency of the peristaltic wave, and fluid properties like viscosity, density, and yield stress, providing a highly versatile platform for simulating both normal and diseased states of biological transport mechanisms. A user-friendly graphical user interface (GUI) is incorporated, designed to facilitate easy input of simulation parameters, execution of simulations, and visualization of results through real-time animations, contour plots, velocity profiles, pressure distributions, wall shear stresses, and particle trajectory mappings. This visualization capability is crucial for understanding the nuanced flow dynamics and identifying regions susceptible to pathological conditions such as flow stagnation, backflow, or excessive mechanical stress which could lead to tissue damage or disease progression. The system also features integrated data analytics and machine learning modules that can analyze simulation outputs to predict optimal parameter configurations for therapeutic interventions or biomedical device design. This predictive capability is particularly valuable in clinical applications where personalized models based on patient-specific anatomical and physiological data can guide the planning of treatments, surgeries, or the design of prosthetic devices tailored to individual needs. The computational framework supports multi-scale modeling, linking cellular or particle-level dynamics with organ-level flow patterns to provide a comprehensive understanding of peristaltic transport from micro to macro scales. This is particularly relevant in fields such as targeted drug delivery, where understanding the interaction between carrier particles and peristaltic motion can enhance the efficacy of treatments. The system is designed to be scalable and compatible with high-performance computing infrastructures, enabling the handling of complex simulations with high resolution and large datasets essential for both research and clinical settings. Additionally, the modular architecture of the system allows for future expansions, including the incorporation of emerging rheological models, updated biomechanical data, or integration with clinical imaging modalities such as MRI, CT scans, or ultrasound data to enhance model fidelity and applicability. The invention is also equipped with diagnostic features that can simulate pathological conditions by altering specific parameters to reflect diseases such as diabetes-induced gastroparesis, achalasia, urinary obstructions, or microvascular complications, thus serving as a valuable tool in both research and clinical diagnostics. Furthermore, the system offers a virtual prototyping environment for biomedical device development, particularly for devices relying on peristaltic mechanisms such as peristaltic pumps, artificial conduits, and implantable drug delivery systems. By allowing designers to simulate the performance of these devices in silico before physical prototyping, the system can significantly reduce development time and costs while enhancing design optimization. From an educational perspective, the system serves as a powerful teaching aid for medical students, biomedical engineers, and researchers by providing interactive and visual insights into the biomechanics of fluid transport in the human body, fostering a deeper understanding of the complex interplay between fluid dynamics and biological structures. The inclusion of comprehensive documentation, tutorials, and support resources further enhances its accessibility to users across various domains, irrespective of their computational expertise. The system's ability to simulate patient-specific scenarios supports the advancement of personalized medicine, enabling healthcare providers to tailor treatments based on simulated predictions of how a patient's unique physiology will respond to specific interventions. Additionally, the invention has potential applications in pharmaceutical research, where understanding the peristaltic transport of drug formulations can inform the design of more effective delivery systems and dosing regimens. The robustness, accuracy, and versatility of the computational system make it a pivotal tool in bridging the gap between theoretical research, clinical practice, and biomedical device engineering. It addresses the longstanding challenges of modeling the true behavior of non-Newtonian fluids in elastic conduits, offering a level of precision and applicability that is currently unmatched in the field. In summary, the "Computational System for Simulating Peristaltic Transport of Non-Newtonian Fluids in Biological Conduits" stands as a comprehensive, adaptable, and advanced solution for modeling, simulating, and analyzing the complexities of biological fluid transport, with broad applications in medical diagnostics, therapeutic planning, biomedical device development, physiological research, and education, ultimately contributing to improved healthcare outcomes, innovative device designs, and enriched scientific knowledge.
, Claims:We Claim:
1. A computational system for simulating peristaltic transport of non-Newtonian fluids in biological conduits, comprising numerical solvers integrated with fluid-structure interaction models to capture the coupling between peristaltic wall motion and non-Newtonian fluid dynamics.

2. The system as claimed in claim 1, wherein the non-Newtonian fluid behavior is modeled using rheological models selected from the group consisting of Power-law, Bingham plastic, Casson, and Herschel-Bulkley models to accurately simulate shear-thinning, shear-thickening, and viscoplastic characteristics.

3. The system as claimed in claim 1, wherein biological conduit properties including elasticity, compliance, wall thickness, wave amplitude, wavelength, and frequency are customizable to reflect specific anatomical and physiological conditions.

4. The system as claimed in claim 1, further comprising a graphical user interface (GUI) configured for real-time input of physiological parameters, visualization of simulation outcomes, and dynamic display of velocity profiles, pressure gradients, wall shear stress, and particle trajectories.

5. The system as claimed in claim 1, wherein multi-scale modeling capabilities link microscale particle interactions and cellular dynamics with macroscale peristaltic flow patterns for comprehensive transport analysis.

6. The system as claimed in claim 1, wherein machine learning algorithms are integrated to optimize simulation parameters, predict flow behaviors under various conditions, and suggest therapeutic or device design interventions based on simulation data.

7. The system as claimed in claim 1, capable of importing clinical imaging data, such as MRI or CT scans, to construct patient-specific models for personalized simulation of peristaltic transport under normal and pathological states.

8. The system as claimed in claim 1, wherein diagnostic simulation modes replicate pathological scenarios such as diabetes-induced gastroparesis, ureteral obstruction, and vascular abnormalities by adjusting conduit and fluid parameters accordingly.

9. The system as claimed in claim 1, applicable for virtual prototyping of biomedical devices such as peristaltic pumps, artificial conduits, and drug delivery systems by enabling in silico testing of device-fluid interactions before physical fabrication.

10. The system as claimed in claim 1, designed with a modular architecture that supports the integration of additional rheological models, updated biomechanical datasets, and future advancements in computational techniques to enhance its simulation precision and applicability across various biomedical domains.